on gene therapy
Elicera's targeted virus against cancer is being studied in China
The agreement with China Medical University is one of the milestones that the company highlights in the report for the second quarter of this year.
Elicera CEO: "iTANK has high potential in the treatment of solid tumors"
Elicera's Q3 report was a read packed with updates...
CombiGene's new CEO talks about his visions for the company
Gene therapy company CombiGenes CEO Jan Nilsson, who has held...
CombiGene's CEO gives a status update
Jan Nilsson
Elicera on AstraZeneca's acquisition of Neogene Therapeutics
Interest in cell treatments is on the rise, which is noticeable...
The CAR T revolution in the fight against cancer
CAR T-cell therapies have shown potential to transform...
Progress with new gene therapy for serious skin disease
A serious skin disease that creates large, painful blisters...
CombiGene about the international patent application
Gene therapy company CombiGene announced this week that it...
CombiGene advances in preclinical and recruits new staff
CombiGene was able to announce on Monday that all quality analyses...
CombiGene pays SEK 1,5 million for new gene therapy asset
As a first payment for the licensing of a...
Billion-dollar deals confirm growing interest in gene therapy
The pharmaceutical giants have discovered gene therapy in earnest
FDA predicts strong boost for cell and gene therapies
The US Food and Drug Administration (FDA) predicts that the number of approved...